CureVac NV
NASDAQ:CVAC
CureVac NV
NASDAQ:CVAC
Price:
4.66
USD
Market Closed
Market Cap:
$1B
Balance Sheet
Balance Sheet Decomposition
CureVac NV
CureVac NV
Balance Sheet Decomposition is not available for
CureVac NV
CureVac NV
Balance Sheet
CureVac NV
CureVac NV
Currency: EUR
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
21
|
31
|
1 323
|
812
|
496
|
402
|
482
|
|
| Cash Equivalents |
21
|
31
|
1 323
|
812
|
496
|
402
|
482
|
|
| Short-Term Investments |
39
|
0
|
0
|
2
|
2
|
2
|
4
|
|
| Total Receivables |
9
|
19
|
4
|
21
|
12
|
23
|
23
|
|
| Accounts Receivables |
7
|
17
|
2
|
19
|
9
|
17
|
17
|
|
| Other Receivables |
2
|
2
|
2
|
3
|
3
|
6
|
6
|
|
| Inventory |
3
|
6
|
15
|
56
|
24
|
25
|
1
|
|
| Other Current Assets |
1
|
1
|
48
|
49
|
51
|
26
|
18
|
|
| Total Current Assets |
73
|
57
|
1 390
|
940
|
584
|
478
|
526
|
|
| PP&E Net |
41
|
62
|
101
|
200
|
242
|
279
|
245
|
|
| PP&E Gross |
41
|
62
|
101
|
200
|
242
|
279
|
245
|
|
| Accumulated Depreciation |
18
|
23
|
45
|
47
|
30
|
37
|
79
|
|
| Intangible Assets |
6
|
6
|
14
|
13
|
19
|
16
|
13
|
|
| Goodwill |
0
|
0
|
0
|
0
|
13
|
12
|
12
|
|
| Note Receivable |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
5
|
5
|
6
|
4
|
3
|
3
|
7
|
|
| Other Assets |
0
|
0
|
0
|
0
|
13
|
12
|
12
|
|
| Total Assets |
126
N/A
|
131
+4%
|
1 511
+1 057%
|
1 158
-23%
|
861
-26%
|
788
-8%
|
803
+2%
|
|
| Liabilities | ||||||||
| Accounts Payable |
9
|
5
|
22
|
128
|
74
|
48
|
17
|
|
| Accrued Liabilities |
12
|
12
|
50
|
47
|
39
|
49
|
27
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
2
|
3
|
4
|
5
|
5
|
5
|
|
| Other Current Liabilities |
7
|
9
|
173
|
180
|
39
|
84
|
23
|
|
| Total Current Liabilities |
28
|
28
|
248
|
358
|
156
|
186
|
72
|
|
| Long-Term Debt |
0
|
77
|
52
|
25
|
37
|
37
|
34
|
|
| Deferred Income Tax |
0
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
65
|
67
|
500
|
87
|
134
|
48
|
0
|
|
| Total Liabilities |
94
N/A
|
173
+85%
|
800
+361%
|
470
-41%
|
327
-30%
|
271
-17%
|
106
-61%
|
|
| Equity | ||||||||
| Common Stock |
1
|
1
|
22
|
23
|
23
|
27
|
27
|
|
| Retained Earnings |
31
|
44
|
690
|
672
|
512
|
490
|
670
|
|
| Treasury Stock |
0
|
0
|
0
|
6
|
2
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
32
N/A
|
43
N/A
|
711
N/A
|
689
-3%
|
533
-23%
|
517
-3%
|
697
+35%
|
|
| Total Liabilities & Equity |
126
N/A
|
131
+4%
|
1 511
+1 057%
|
1 158
-23%
|
861
-26%
|
788
-8%
|
803
+2%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
176
|
176
|
180
|
187
|
195
|
224
|
224
|
|
Switch to:
Switch to:
See Also
Discover More
